SIGRID’s Glucose Stabiliser Demonstrates Clinical Efficacy and U.S. Commercial Momentum Amid Growing Demand for Metabolic Health Solutions
Stockholm, Sweden – June 9, 2025. SIGRID, the Swedish healthtech innovator behind the patented...
Stockholm, Sweden – June 9, 2025. SIGRID, the Swedish healthtech innovator behind the patented...
Eckert-Lind, C. et al. Worldwide secular trends in age at pubertal onset assessed by breast development among girls. JAMA Pediatr....
AMA Update covers a range of health care topics affecting the lives of physicians, residents, medical students and patients. From...
The Pennington Biomedical Research Center is at the forefront of medical discovery as it relates to understanding the triggers of...
The proportion of new users of GLP-1 receptor agonists without type 2 diabetes markedly increased over the past decade, and...